Strides Pharma Science Singapore arm to acquire 100 percent stake in Amexel

Published On 2025-03-17 12:08 GMT   |   Update On 2025-03-17 12:19 GMT

Bangalore: Strides Pharma Global Pte. Limited (SPG), a step-down wholly-owned Subsidiary of Strides Pharma Science Limited in Singapore, has entered into a Share Purchase Agreement to acquire 100 percent stake in Amexel for a nominal consideration of USD 10.

In a recent BSE filing, the Company's Singapore arm proposed to create a platform that shall foster introductions, collaborations, procurement and business engagement between pharmaceutical manufacturers and suppliers of India, China, and other Southeast Asian countries.

"In this regard, it is proposed to acquire 100% stake in Amexel Pte. Ltd., Singapore (Amexel), which will be utilized as the entity for the above business platform," the Company stated.

Amexel is a company incorporated under the laws of Singapore on March 22, 2023 and has its Registered Office at 36 Robinson Road, #13-06 City House, Singapore 068877.

Amexel is yet to commence its operations. 
The acquisition is anticipated to be completed by March 31, 2025.
Amexel, as WOS of SPG, shall focus on in-licensing, technology transfers, and the procurement of technical and manufacturing expertise for the production of pharmaceutical products at Strides’ manufacturing facilities (or those of its affiliates) as well as other manufacturers in India, identifying qualified and approved suppliers, sourcing partners, and providers of APIs, Raw Materials and Packaging materials, building partnerships with distributors, commercial partners, and customers to support the supply, distribution, and commercialization of products across various territories.

"Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products," the release stated.

Read also: Strides Pharma Science arm gets USFDA nod for Acetaminophen and Ibuprofen Tablets

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News